MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$929,161
Unit: Dollar
Positive Cash Flow Breakdown
Net loss from change in fair val...
Amortization of deferred offerin...
Accounts payable and accrued exp...
Others
Negative Cash Flow Breakdown
Net loss
Purchases of intangible assets
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-5,849,893
-970,972
279,070
-3,473,150
Amortization expense
14,531
-24,140
-
38,591
Depreciation and amortization
-
-
52,746
-
Stock-based compensation expense
419,233
280,830
256,380
162,865
Non-cash operating lease expense
-
-
1,172
-
Common stock issued in exchange for services
-
-
0
250,000
Net loss from change in fair value of derivative liability instrument
-3,341,568
697,561
2,574,971
-
Gain from change in fair value of forward contract liability
-
-
-380,442
-
Amortization of deferred offering cost
638,747
477,647
496,948
-
Non-cash operating lease effect
-
-
-
1,165
Amortization of debt discount
117,608
-
-
-
Prepaids and other current assets
-104,355
123,738
-68,283
-36,742
Accounts payable and accrued expenses
290,487
-613,464
664,303
1,597,153
Net cash used in operating activities
-923,364
-1,632,807
-1,176,267
-1,386,634
Purchases of intangible assets
5,798
12,227
31,441
121,545
Net cash used in investing activities
-5,798
-12,227
-31,441
-121,545
Cash receipt from stock subscription receivable
0
1,070,000
-
-
Proceeds from issuance of stock, net of issuance costs
-
-
3,177,696
3,741,736
Proceeds from avenue capital loan agreement
1
6,716,561
-
-
Net cash provided by financing activities
1
7,786,561
3,177,696
3,741,736
Net increase in cash and cash equivalents
-929,161
6,141,527
1,969,988
2,233,557
Cash and cash equivalents at beginning of the period
11,217,671
5,076,144
3,106,156
872,599
Cash and cash equivalents at end of the period
10,288,510
11,217,671
5,076,144
3,106,156
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from avenue
capital loan agreement
$1
Net cash provided by
financing activities
$1
Net increase in cash
and cash...
-$929,161
Canceled cashflow
$1
Net loss from change
in fair value of...
-$3,341,568
Amortization of deferred
offering cost
$638,747
Stock-based compensation
expense
$419,233
Accounts payable and
accrued expenses
$290,487
Amortization of debt discount
$117,608
Prepaids and other
current assets
-$104,355
Amortization expense
$14,531
Net cash used in
operating activities
-$923,364
Net cash used in
investing activities
-$5,798
Canceled cashflow
$4,926,529
Net loss
-$5,849,893
Purchases of intangible
assets
$5,798
Buy us a coffee
Turn Therapeutics Inc. (TTRX)
Turn Therapeutics Inc. (TTRX)